Home » ARDANA REPORTS TESTOSTERONE CREAM TRIAL DATA
ARDANA REPORTS TESTOSTERONE CREAM TRIAL DATA
Ardana has reported that its experimental testosterone cream had passed a key intermediate clinical trial involving 42 patients diagnosed with male hypogonadism.
The company's Phase II study involved three groups, each consisting of 14 patients, who received in random order a single application of the testosterone cream at varying dose levels or a placebo treatment. Both placebo and active cream were applied to one upper arm only, the firm added.
The condition -- also known as testosterone deficiency -- refers to the inability of the testicles to produce testosterone, sperm or both. Hypogonadism can result in sexual problems, decreased beard and body hair, breast enlargement, and muscle loss.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
07May
-
14May
-
30May